Form 4 for ISRG Intuitive Surgical
Accepted 2025-10-29 00:00:00 ET · period of report 2025-10-28 · accession 0001632901-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-29 | 2025-10-28+ | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $548.34 | -7,687 | 0 | -100% | -$4.22M |
| DM | 2025-10-29 | 2025-10-28+ | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $233.85 | +7,687 | 125 | New | +$1.80M |
| DM | 2025-10-29 | 2025-10-28+ | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -7,687 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-28 | S | D | 5,030 | $548.43 | 353 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-10-28 | M | A | 1,153 | $229.39 | 1,506 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-28 | S | D | 1,153 | $548.43 | 353 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-10-28 | M | A | 1,379 | $208.90 | 1,732 | D | — | — | |
| 5 | Common | Common Stock | 2025-10-28 | S | D | 1,379 | $548.43 | 353 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2025-10-28 | M | A | 5,030 | $242.34 | 5,383 | D | — | — | |
| 7 | Common | Common Stock | 2025-10-29 | S | D | 125 | $543.00 | 0 | D | — | — | |
| 8 | Common | Common Stock | 2025-10-29 | M | A | 125 | $208.90 | 125 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-28 | M | D | 1,379 | $0.00 | 626 | D | $208.90 · — to 2029-08-28 | 1,379 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-29 | M | D | 125 | $0.00 | 501 | D | $208.90 · — to 2029-08-28 | 125 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-28 | M | D | 1,153 | $0.00 | 1,676 | D | $229.39 · — to 2030-02-27 | 1,153 Common Stock | (F4) 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-28 | M | D | 5,030 | $0.00 | 0 | D | $242.34 · — to 2030-08-28 | 5,030 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |